The partnership is focused on advancing health equity by putting the cancer models in the hands of oncologists. Many countries with socialized medicine need and want to ensure that appropriate treatment options are made available to patients.  This is especially important, given many government managed systems frequently have a fixed allocation of chemo and other cancer treatments.  In this context, MyCancerJourney (MCJ) is sold as a SaaS.